Compass Therapeutics Inc. (CMPX): Price and Financial Metrics
GET POWR RATINGS... FREE!
CMPX Stock Price Chart Interactive Chart >
CMPX Price/Volume Stats
| Current price | $2.80 | 52-week high | $5.80 |
| Prev. close | $2.70 | 52-week low | $1.25 |
| Day low | $2.71 | Volume | 347,600 |
| Day high | $2.84 | Avg. volume | 173,095 |
| 50-day MA | $2.22 | Dividend yield | N/A |
| 200-day MA | $2.60 | Market Cap | 283.60M |
Compass Therapeutics Inc. (CMPX) Company Bio
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel bispecific targeting PD-1 and PD-L1, and a portfolio of bispecific and monoclonal antibodies at various stages of pre-clinical development. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.
CMPX Price Returns
| 1-mo | -7.28% |
| 3-mo | 124.00% |
| 6-mo | -4.11% |
| 1-year | -42.86% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -11.67% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...